JDRF CEO Jeffrey Brewer Answers Your Questions and Researchers Honored at Annual Conference!
Video Q&A with Jeffrey Brewer, JDRF President & CEO
JDRF Researchers Honored for Scientific Excellence
Also at last week’s Annual Conference, JDRF Researchers were honored for scientific excellence and outstanding work on diabetes research. Three awards were presented during JDRF’s Annual Conference in Denver, Colorado: the David Rumbough Award for Scientific Excellence, the Gerold & Kayla Grodsky Basic Research Scientist Award and the Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award.
Established almost 40 years ago by actress Dina Merrill in honor of her late son, David, the Rumbough Award is presented annually in recognition of outstanding achievement in diabetes research and service to JDRF. This year’s recipients are John A. Todd, Ph.D. and Alvin C. Powers, M.D.
The Gerold & Kayla Grodsky Basic Research Scientist Award is presented annually to a scientist, or team of scientists, who has demonstrated excellent leadership and innovation in type 1 diabetes research. This year’s award was presented to Pedro L. Herrera, Ph.D.
The Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award recognizes outstanding clinical and translational research that has the potential to relieve the day-to-day burdens of type 1 diabetes, and ultimately achieve a life free of the disease and its complications. The prestigious award is named in honor of Ms. Moore – who has type 1 diabetes – and Dr. Levine for their extraordinary commitment to JDRF’s mission of finding better treatments and a cure for type 1 diabetes and its complications through the support of research. The ninth annual award was presented to the JDRF Continuous Glucose Monitoring Study Group, a multi-center team of scientists. A total of 16 high-impact publications demonstrating the positive impact that CGM devices have in diabetes management have been authored and published by the study group. View the full list of award recipients.
“These prestigious awards are a way to honor these scientists, whose dedication and superb scientific contributions have made a tremendous impact on type 1 diabetes research,” said Dr. Richard Insel, Chief Scientific Officer at JDRF. “Their outstanding work solidifies our commitment to finding better treatments and a cure for type 1 diabetes and its complications, and strengthens our resolve that we will ultimately cure this disease.”
Read the complete Press Release: Researchers Honored for Scientific Excellence and Researchers from Landmark CGM Trials Receive “Excellence in Clinical Research Award”.
To learn more about the JDRF Dallas chapter, visit our JDRF Dallas website!